Achieve life sciences announces participation in november investor conferences

Seattle, wash and vancouver, british columbia, nov. 04, 2021 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that its management team will hold one-on-one investor meetings at the alliance global partners' (a.g.p.) biotech & specialty pharma conference and the torrey hills capital emerging growth conference during november 2021. details are as follows:
ACHV Ratings Summary
ACHV Quant Ranking